Literature DB >> 26872696

Erythropoeitin Signaling in Macrophages Promotes Dying Cell Clearance and Immune Tolerance.

Bangwei Luo1, Woting Gan1, Zongwei Liu1, Zigang Shen1, Jinsong Wang1, Rongchen Shi1, Yuqi Liu1, Yu Liu1, Man Jiang1, Zhiren Zhang2, Yuzhang Wu3.   

Abstract

The failure of apoptotic cell clearance is linked to autoimmune diseases, nonresolving inflammation, and developmental abnormalities; however, pathways that regulate phagocytes for efficient apoptotic cell clearance remain poorly known. Apoptotic cells release find-me signals to recruit phagocytes to initiate their clearance. Here we found that find-me signal sphingosine 1-phosphate (S1P) activated macrophage erythropoietin (EPO) signaling promoted apoptotic cell clearance and immune tolerance. Dying cell-released S1P activated macrophage EPO signaling. Erythropoietin receptor (EPOR)-deficient macrophages exhibited impaired apoptotic cell phagocytosis. EPO enhanced apoptotic cell clearance through peroxisome proliferator activated receptor-γ (PPARγ). Moreover, macrophage-specific Epor(-/-) mice developed lupus-like symptoms, and interference in EPO signaling ameliorated the disease progression in lupus-like mice. Thus, we have identified a pathway that regulates macrophages to clear dying cells, uncovered the priming function of find-me signal S1P, and found a role of the erythropoiesis regulator EPO in apoptotic cell disposal, with implications for harnessing dying cell clearance.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26872696     DOI: 10.1016/j.immuni.2016.01.002

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  80 in total

1.  Epo receptor signaling in macrophages alters the splenic niche to promote erythroid differentiation.

Authors:  Yuanting Chen; Jie Xiang; Fenghua Qian; Bastihalli T Diwakar; Baiye Ruan; Siyang Hao; K Sandeep Prabhu; Robert F Paulson
Journal:  Blood       Date:  2020-07-09       Impact factor: 22.113

2.  Erythropoietin Treatment Ameliorates Lupus Nephritis of MRL/lpr Mice.

Authors:  Zeming Zhang; Dongmei Liu; Xiaoli Zhang; Xiaofei Wang
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

3.  Identification and transcriptome analysis of erythroblastic island macrophages.

Authors:  Wei Li; Yaomei Wang; Huizhi Zhao; Huan Zhang; Yuanlin Xu; Shihui Wang; Xinhua Guo; Yumin Huang; Shijie Zhang; Yongshuai Han; Xianfang Wu; Charles M Rice; Gang Huang; Patrick G Gallagher; Avital Mendelson; Karina Yazdanbakhsh; Jing Liu; Lixiang Chen; Xiuli An
Journal:  Blood       Date:  2019-05-17       Impact factor: 22.113

Review 4.  Programmed Cell Death and Inflammation: Winter Is Coming.

Authors:  Joseph P Kolb; Thomas H Oguin; Andrew Oberst; Jennifer Martinez
Journal:  Trends Immunol       Date:  2017-07-19       Impact factor: 16.687

5.  Dying Neurons Utilize Innate Immune Signaling to Prime Glia for Phagocytosis during Development.

Authors:  Colleen N McLaughlin; Jahci J Perry-Richardson; Jaeda C Coutinho-Budd; Heather T Broihier
Journal:  Dev Cell       Date:  2019-02-07       Impact factor: 12.270

6.  Gut check: dead cell samples leads to tolerant examples.

Authors:  Thomas H Oguin; Jennifer Martinez
Journal:  Cell Death Differ       Date:  2017-06-23       Impact factor: 15.828

Review 7.  Living on the Edge: Efferocytosis at the Interface of Homeostasis and Pathology.

Authors:  Sho Morioka; Christian Maueröder; Kodi S Ravichandran
Journal:  Immunity       Date:  2019-05-21       Impact factor: 31.745

Review 8.  Sphingolipid metabolism in cancer signalling and therapy.

Authors:  Besim Ogretmen
Journal:  Nat Rev Cancer       Date:  2017-11-17       Impact factor: 60.716

Review 9.  Erythropoiesis, EPO, macrophages, and bone.

Authors:  Joshua T Eggold; Erinn B Rankin
Journal:  Bone       Date:  2018-03-15       Impact factor: 4.398

Review 10.  The Dynamics of Apoptotic Cell Clearance.

Authors:  Michael R Elliott; Kodi S Ravichandran
Journal:  Dev Cell       Date:  2016-07-25       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.